Redwood City, CA, United States of America

Menlo Therapeutics Inc.

Calculating rank

USPTO Granted Patents = 10

% Expired Patents = 70.0

Forward Citations = 54

Loading Chart...

4 inventors (with patents filed for the assignee):

Xiaoming Zhang (10 out of 68 patents)

Edward F Schnipper (10 out of 16 patents)

Andrew J Perlman (10 out of 14 patents)

4. James W Larrick (10 out of 56 patents)

10 patents: Sort by Forward Citations

1. 10702499 - Use of NK-1 receptor antagonists in pruritus (2020-07-07),

2. 10617671 - Use of NK-1 receptor antagonist serlopitant in pruritus (2020-04-14),

3. 10278953 - Use of NK-1 receptor antagonist serlopitant in pruritus (2019-05-07),

4. 10278952 - Use of NK-1 receptor antagonists in pruritus (2019-05-07),

5. 9974769 - Use of NK-1 receptor antagonist serlopitant in pruritus (2018-05-22),

6. 9968588 - Use of NK-1 receptor antagonists in pruritus (2018-05-15),

7. 9737508 - Use of NK-1 receptor antagonists in pruritus (2017-08-22),

8. 9737507 - Use of NK-1 receptor antagonist serlopitant in pruritus (2017-08-22),

9. 9486439 - Use of NK-1 receptor antagonist serlopitant in pruritus (2016-11-08),

10. 9474741 - Use of NK-1 receptor antagonists in pruritus (2016-10-25),

Company Overview

Menlo Therapeutics Inc. is a biopharmaceutical company based in Redwood City, California, focused on developing innovative therapies for dermatological conditions. The company specializes in the research and commercialization of novel treatments that address unmet medical needs in skin health. Leveraging advanced drug delivery technologies, Menlo aims to enhance patient outcomes through effective and safe therapeutic options, positioning itself as a key player in the dermatology sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#152 in Redwood City, CA

#7,121 in California

#29,892 in US

#56,119 in the World

Redwood City, CA, United States of America